University of Nebraska-Lincoln, School of Biological Sciences and Nebraska Center for Virology, Lincoln, NE 68583-0900, USA.
Cell Immunol. 2010;262(2):89-95. doi: 10.1016/j.cellimm.2010.02.008. Epub 2010 Feb 24.
CD4 T cells have traditionally been regarded as helpers and regulators of adaptive immune responses; however, a novel role for CD4 T cells as direct mediators of protection against viral infections has emerged. CD4 T cells with cytolytic potential have been described for almost 40 years, but their role in host protection against infectious disease is only beginning to be realized. In this review, we describe the current literature identifying these cells in patients with various infections, mouse models of viral infection and our own work investigating the development of cytolytic CD4 cells in vivo and in vitro. CD4 CTL are no longer considered an artefact of cell culture and may play a physiological role in viral infections such as EBV, CMV, HIV and influenza. Therefore, vaccine strategies aimed at targeting CD4 CTL should be developed in conjunction with vaccines incorporating B cell and CD8 CTL epitopes.
CD4 T 细胞传统上被认为是适应性免疫反应的辅助者和调节剂;然而,CD4 T 细胞作为直接介导抗病毒感染保护的新角色已经出现。具有细胞毒性潜力的 CD4 T 细胞已经被描述了将近 40 年,但它们在宿主对抗传染病中的作用才刚刚开始被认识到。在这篇综述中,我们描述了目前的文献,这些文献确定了各种感染患者、病毒感染的小鼠模型以及我们自己的工作中体内和体外细胞毒性 CD4 细胞的发展。CD4 CTL 不再被认为是细胞培养的一种假象,它们可能在 EBV、CMV、HIV 和流感等病毒感染中发挥生理作用。因此,应该与包含 B 细胞和 CD8 CTL 表位的疫苗一起开发针对 CD4 CTL 的疫苗策略。